Determinants of plague susceptibility and resistance
Determinants of plague susceptibility and resistance
批准号:
10245980
负责人:
Dominique M. Missiakas
金额:
$40.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-14 至 2022-08-31
关键词:
AllelesAnimalsAnnexinsAntibodiesAntigensBacteriaBindingBlood CirculationBubonic PlagueCRISPR/Cas technologyCanis familiarisCell physiologyCellsCessation of lifeChemotactic FactorsChemotaxisComplexDevelopmentDiseaseDockingElementsExhibitsFPR1 geneG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGenesGenomic ImprintingHumanHuman VolunteersImmuneImmune responseImmune systemImmunityInfectionInjectionsIntegration Host FactorsKnockout MiceLigandsLinkMammalsMediatingMembraneModelingMolecularMusMutagenesisMutationN-Formylated PeptideNeedlesPathogenesisPhenotypePlaguePlasmidsPneumonic PlaguePopulationPredispositionProteinsResistanceSamplingSignal TransductionSingle Nucleotide PolymorphismTestingTimeType III Secretion System PathwayVariantVirulenceWild Type MouseWorkYersiniaYersinia pestisantibody inhibitorinhibitor/antagonistmacrophagemonocytemortalitymouse modelneutrophilpandemic diseasereceptorresistance alleleresponsescreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Yersinia pestis, the plague agent, caused major pandemics, reiteratively killing most of the human population.
The extraordinary mortality of plague is thought to have shaped the human immune system, however its
genetic imprint was not known. Y. pestis employs a virulence-plasmid encoded type III secretion system
(T3SS) to kill immune cells, thereby replicating unencumbered in the bloodstream of infected hosts. Of
particular importance is LcrV, the plague-protective antigen and needle-cap protein of the T3SS, which enables
transport of Yersinia effectors (Yops) into immune cells. To identify the human plague receptor for Y. pestis
T3SS, we screened for inhibitors that interfere with effector translocation. Ligands of formyl-peptide receptor 1
(FPR1) and antibodies against FPR1 block Y. pestis T3SS injection into human primary neutrophils and
cultured immune cells. CRISPR-Cas9 mutagenesis demonstrated that FPR1 is essential for Y. pestis T3SS-
mediated killing of human monocytes. Pulldown of tagged FPR1 from Y. pestis infected macrophages revealed
the association between FPR1 and T3SS needle complexes, which are comprised of LcrV and YopD. These
findings establish FPR1, a G-protein coupled receptor that activates chemotaxis in response to N-
formylpeptides or annexin 1 signaling, as the plague receptor on human immune cells. In wild-type mice,
plague infection is characterized by Y. pestis T3SS-induced obliteration of the immune system and high
mortality, whereas N-formylpeptide receptor deficient (mFpr1-/-) mice exhibit delayed time-to-death, increased
survival and the development of protective immunity. Immune cells of mFpr1-/- mice are partially resistant to
T3SS and defective for chemotaxis towards Y. pestis. Human FPR1 is a polymorphic gene. Single nucleotide
polymorphisms (SNPs) are more frequent in FPR1 than in other human genes. Screening neutrophils of
human volunteers for resistance to Y. pestis T3SS, we identified FPR1R190W as a candidate resistance allele.
This proposal explores the molecular mechanisms linking Y. pestis T3SS and LcrV with human FPR1 and
other host factors to gain deep understanding into the pathogenesis of plague and the mechanisms that
shaped FPR1 and human immune responses. Other work will characterize the plague receptor on immune
cells of mice, testing the hypothesis that mutations in FPR1 confer resistance to plague disease. N-
formylpeptide receptors of different animal species will be characterized to understand plague susceptibility
and resistance in mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biocontainment Research Support Service(s) Core
-
批准号:10793952
-
项目类别:
-
资助金额:$78.33万
-
财政年份:2023
-
负责人:Dominique M. Missiakas
-
依托单位:
Optimal adjuvant/antigen formulation toward a Staphylococcus aureus human vaccine
-
批准号:10383513
-
项目类别:
-
资助金额:$25.39万
-
财政年份:2022
-
负责人:Dominique M. Missiakas
-
依托单位:
Development of a Vaccine for Staphylococcal Infections
-
批准号:10255984
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2021
-
负责人:Dominique M. Missiakas
-
依托单位:
Antibody therapy of MRSA colonization and infection
-
批准号:10307576
-
项目类别:
-
资助金额:$52.42万
-
财政年份:2019
-
负责人:Dominique M. Missiakas
-
依托单位:
Antibody therapy of MRSA colonization and infection
-
批准号:10525253
-
项目类别:
-
资助金额:$52.42万
-
财政年份:2019
-
负责人:Dominique M. Missiakas
-
依托单位:
Molecular basis and intervention of Staphylococcus aureus agglutination
-
批准号:8817809
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2014
-
负责人:Dominique M. Missiakas
-
依托单位:
Molecular basis and intervention of Staphylococcus aureus agglutination
-
批准号:8816265
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Dominique M. Missiakas
-
依托单位:
Molecular basis and intervention of Staphylococcus aureus agglutination
-
批准号:9180674
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Dominique M. Missiakas
-
依托单位:
Therapies of infections caused by gram-positive bacteria
-
批准号:8448669
-
项目类别:
-
资助金额:$54.17万
-
财政年份:2013
-
负责人:Dominique M. Missiakas
-
依托单位:
Animal Research and Immunology Core
-
批准号:8448677
-
项目类别:
-
资助金额:$48.02万
-
财政年份:2013
-
负责人:Dominique M. Missiakas
-
依托单位:
Animal Research and Immunology Core
-
批准号:8233346
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2011
-
负责人:Dominique M. Missiakas
-
依托单位:
Therapies of infections caused by gram-positive bacteria
-
批准号:8233340
-
项目类别:
-
资助金额:$54.56万
-
财政年份:2011
-
负责人:Dominique M. Missiakas
-
依托单位:
Therapies of infections caused by gram-positive bacteria
-
批准号:7672012
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2009
-
负责人:Dominique M. Missiakas
-
依托单位:
Animal Research and Immunology Core
-
批准号:7672088
-
项目类别:
-
资助金额:$44.58万
-
财政年份:2009
-
负责人:Dominique M. Missiakas
-
依托单位:
ESAT-6 Secretion in Staphylococcus Aureus
-
批准号:8389635
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2008
-
负责人:Dominique M. Missiakas
-
依托单位:
ESAT-6 Secretion in Staphylococcus Aureus
-
批准号:7742680
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2008
-
负责人:Dominique M. Missiakas
-
依托单位:
ESAT-6 Secretion in Staphylococcus Aureus
-
批准号:7991777
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2008
-
负责人:Dominique M. Missiakas
-
依托单位:
ESAT-6 Secretion in Staphylococcus Aureus
-
批准号:8197165
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2008
-
负责人:Dominique M. Missiakas
-
依托单位:
ESAT-6 Secretion in Staphylococcus Aureus
-
批准号:7591510
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2008
-
负责人:Dominique M. Missiakas
-
依托单位:
Surface Proteins of Bacillus anthracis
-
批准号:8391067
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2007
-
负责人:Dominique M. Missiakas
-
依托单位:
海外基金